title: Acquired immune dysfunction in rabbits experimentally infected with an infectious molecular clone of the bovine immunodeficiency virus (BIV127).
abstract: To investigate the effect of bovine immunodeficiency virus (BIV) infection on the rabbit immune system, we studied the proliferative responses of peripheral blood lymphocytes (PBLs) of rabbits experimentally inoculated with BIV. All BIV127-inoculated rabbits seroconverted after 6 weeks and remained seropositive over a prolonged period of time. Assays for specific lymphocyte reactivity to concanavalin A (Con A) were performed monthly for over 1 year. One-hundred percent of infected rabbits developed abnormally low T cell responses, as measured by Con A stimulation. By 3 months postinoculation, the PBL response to Con A was diminished and remained depressed for 6 months. All animals were clinically asymptomatic within 14 months of BIV inoculation. By 15 and 16 months postinoculation, two of three infected rabbits exhibited recurrent lowering of the T cell responsiveness including a decrease in absolute PBL counts. One of these animals died unexpectedly. Our results further confirmed that a functional impairment of lymphocytes was induced early in the course of BIV infection, prior to clinical disease. These findings suggested that BIV infection may mimic asymptomatic infection of human immunodeficiency virus (HIV) and provided further evidence of the importance of BIV-induced disease in rabbits as a relevant model for the study of AIDS.
authors.affiliation: Laboratorio Virus Animales, Centro de Microbiologia y Biologia Celular, Instituto Venezolano de Investigaciones Cientificas (IVIC), Caracas, Venezuela.
authors.forename: Z
authors.initials: Z
authors.lastname: Kalvatchev
authors.forename: R
authors.initials: R
authors.lastname: Walder
authors.forename: M
authors.initials: M
authors.lastname: Barrios
authors.forename: D
authors.initials: D
authors.lastname: Garzaro
mesh_terms: D000818:Animals; D000914:Antibodies, Viral / Q000096:biosynthesis; D003001:Cloning, Molecular; D003208:Concanavalin A / Q000494:pharmacology; D016087:Immunodeficiency Virus, Bovine / Q000276:immunology* / Q000472:pathogenicity; D007153:Immunologic Deficiency Syndromes / Q000276:immunology / Q000821:virology*; D016180:Lentivirus Infections / Q000276:immunology* / Q000821:virology; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology; D008297:Male; D011817:Rabbits
chemical_list: D000914:Antibodies, Viral; D003208:Concanavalin A